Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Non-Current Deffered Revenue: 2017-2018

Historic Non-Current Deffered Revenue for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $9,000.

  • Astria Therapeutics' Non-Current Deffered Revenue fell 89.89% to $9,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $9,000, marking a year-over-year decrease of 89.89%. This contributed to the annual value of $9,000 for FY2018, which is 89.89% down from last year.
  • Latest data reveals that Astria Therapeutics reported Non-Current Deffered Revenue of $9,000 as of FY2018, which was down 89.89% from $89,000 recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Non-Current Deffered Revenue ranged from a high of $89,000 in FY2017 and a low of $9,000 during FY2018.
  • For the 2-year period, Astria Therapeutics' Non-Current Deffered Revenue averaged around $49,000, with its median value being $49,000 (2017).
  • Data for Astria Therapeutics' Non-Current Deffered Revenue shows a maximum YoY tumbled of 89.89% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows Astria Therapeutics' Non-Current Deffered Revenue stood at $89,000 in 2017, then plummeted by 89.89% to $9,000 in 2018.